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Abstract
Deciphering the cellular immunome of a bacterial pathogen is challenging due to the enormous number of putative
peptidic determinants. State-of-the-art prediction methods developed in recent years enable to significantly reduce the
number of peptides to be screened, yet the number of remaining candidates for experimental evaluation is still in the range
of ten-thousands, even for a limited coverage of MHC alleles. We have recently established a resource-efficient approach for
down selection of candidates and enrichment of true positives, based on selection of predicted MHC binders located in high
density ‘‘hotspots’’ of putative epitopes. This cluster-based approach was applied to an unbiased, whole genome search of
Francisella tularensis CTL epitopes and was shown to yield a 17–25 fold higher level of responders as compared to randomly
selected predicted epitopes tested in Kb/Db C57BL/6 mice. In the present study, we further evaluate the cluster-based
approach (down to a lower density range) and compare this approach to the classical affinity-based approach by testing
putative CTL epitopes with predicted IC50 values of ,10 nM. We demonstrate that while the percent of responders
achieved by both approaches is similar, the profile of responders is different, and the predicted binding affinity of most
responders in the cluster-based approach is relatively low (geometric mean of 170 nM), rendering the two approaches
complimentary. The cluster-based approach is further validated in BALB/c F. tularensis immunized mice belonging to
another allelic restriction (Kd/Dd) group. To date, the cluster-based approach yielded over 200 novel F. tularensis peptides
eliciting a cellular response, all were verified as MHC class I binders, thereby substantially increasing the F. tularensis dataset
of known CTL epitopes. The generality and power of the high density cluster-based approach suggest that it can be a
valuable tool for identification of novel CTLs in proteomes of other bacterial pathogens.
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Introduction
F. tularensis, the causative infective agent of the acute tularemia
disease, is a facultative intracellular pathogen. The bacterium has
a broad range of host specificities and its clinical manifestation and
disease severity depend on the route of infection and on the
infecting strain. Inhalation of as few as 15 CFU of the more
virulent strains (F. tularensis tularensis type A) is sufficient to infect
humans, and without treatment the mortality rate for respiratory
disease is 30–60% [1,2,3]. This, together with interest in F.
tularensis as a biological warfare agent led to its classification in
category A of the CDC list of bioterrorism agents. To date, there is
no available licensed vaccine against F. tularensis. The restricted
efficacy of the sole prophylactic vaccine available, the attenuated
live vaccine strain (LVS), motivated extensive research efforts
attempted at identification of alternative vaccine formulations as a
countermeasure, including exploration of different live and killed
attenuated strains, and identification of components of subunit
vaccines [4,5,6,7,8,9,10]. Taken together with the well document-
ed evidence on contribution of the cellular response to protection
against the intracellular F. tularensis [11], identification of
determinants which could elicit an effective cellular-mediated
immune response is crucial. Nevertheless, the knowledge on F.
tularensis epitopes, and more specifically on cytotoxic T-cell (CTL)
epitopes is extremely limited (www.immuneepitope.org). Recent
studies targeted at large-scale identification of CTL epitopes in F.
tularensis were restricted to limited pre-defined subsets of source
proteins, preselected on the basis of particular considerations, e.g.
secreted proteins [12,13].
Recently, we developed and established an approach for a
whole genome immune-analysis of a bacterial genome, aiming at
the unbiased selection of putative CTL epitopes [14]. The
approach is based on mapping of immunological ‘‘hotspots’’
(regions of 8–25 amino acids harboring consecutive predicted
MHC binders, denoted as clusters), and selection of highly-dense
epitope clusters for further experimental evaluation (the density of
a cluster being defined as the number of peptides per cluster
length, and the densities of the clusters selected range from 1.0–
1.4). A total of 1240 peptides were tested by an EliSpot assay for
their potential to elicit an immune response as reflected by their
ability to stimulate lymphocytes and induce IFNc production (such
peptides are referred in the text as responders). This screen
resulted in identification of 127 responders, which constitute
10.2% of the tested peptides. The cluster-based method was
demonstrated to be a strategy for enrichment (17–25 fold) of true
positive responders in comparison to a randomly selected set of
predicted peptides which are unrelated to clusters. The method
was first applied for clusters harboring a very high density of
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limited set of proteins (51 proteins, see Figure 1, Subset I). Along
with the high success rate obtained by the cluster-based method,
some important issues remained to be further clarified in order to
determine both the generality of the approach developed as well as
to compare its performance with respect to an alternative
approach of high affinity-based selection. Accordingly, the
following topics were evaluated experimentally:
1. Investigating the effect of extension of both the protein number
covered by the selected putative epitopes, and the range of
densities tested (0.8–1.0).
2. Examining whether the high success rate obtained by the
cluster-based approach is indeed related to the epitope
clustering and not to some unique characteristics of the
parental proteins (e.g., membranal).
3. Assessing the success rate of the cluster-based approach in
comparison to the conventional, well established strategy based
solely on the predicted binding affinity of the peptide to the
MHC molecule (10 nM and lower).
4. Validating the cluster-based approach in another animal model
with a different allelic restriction - BALB/c, in addition to the
original C57BL/6 model.
In order to address all four issues raised above, nearly 700
additional predicted MHC binders were synthesized and tested for
their ability to elicit a cellular response. The results obtained in the
present study strongly support and reinforce the strength of the
approach of selecting putative CTL epitopes from epitope-rich
clusters as both a reductive/filtering and enrichment method of
CTL positive responders. This study also provides insight into the
potential of the cluster-based approach and its added value in
relation to the conventional high affinity-based approach.
Results
The general strategy employed for selection of putative peptides
for experimental evaluation is summarized in the flowchart
presented in Figure 1. Our previous study described in detail the
screen conducted on 1740 putative CTL epitopes, preselected
from a total of 90,879 predicted MHC binders [14]. The 1740
putative epitopes constitute two subsets of peptides: (I) Subset I -
was derived from regions rich in overlapping peptides predicted to
be MHC binders with binding affinity threshold of 1000 nM.
These regions were denoted as ‘‘hotspots’’ or clusters of epitopes,
operationally defined as polypeptides of 8–25 amino acids,
harboring at least 2 consecutive predicted epitopes. Clusters were
further ranked according to their calculated density (i.e. number of
putative epitopes per cluster length), and top-ranking clusters
having densities 1.0–1.4 were further considered, encompassing a
total of 1240 peptides; (II) Subset II - included 500 predicted MHC
binders which were randomly selected, regardless of their location
in clusters, and evaluated as a validation control set to the cluster-
based selection approach (Figure 1). In the current study, we tested
the potential of additional categories of preselected peptides, which
were divided into three peptide subsets (Subset III, Subset IV and
Subset V – Figure 1). These subsets were used to address the issues
raised in the Introduction, regarding the generality of the cluster-
based approach and its potential strength and/or weakness as
compared to the high affinity-based selection approach (as detailed
below). The new Subsets III, IV and V were evaluated
experimentally with regard to their potential to elicit a T-cell
response. In all down selection steps referred to in Figure 1 as :
‘‘Selected for evaluation’’ (Subset III, IV and V), the clusters or
peptides are selected at random as an operational filter for
reduction of number of peptides to be experimentally tested,
unlike Subset II, where selection of peptides was at random with
respect to clusters. In addition to Subsets I–V which were all
evaluated on C57BL/6 mice (Kb/Db alleles), we selected for
analysis a set of peptides for evaluation in BALB/c mice which
belong to a different allelic group (Kd/Dd). Experimental
evaluation of all various subsets was carried out using splenocytes
isolated from mice (C57BL/6 or BALB/c, according to the
peptide subset) intranasally immunized with a sub-lethal dose of
live LVS. These splenocytes were co-incubated with the individual
peptides, and the extent of stimulation and subsequent IFNc
production was assessed by an EliSpot assay (Materials &
Methods).
Assessment of the cluster-based approach in a density
range of 0.8–1.0 (Subset III)
Out of a total of 23,050 mapped clusters of putative epitopes,
only 104 clusters exhibited a density of 1.0–1.4 (e.g. a given cluster
of 25 amino acids contains 25–35 predicted epitopes). We now
expand the range of cluster densities to less than 1.0 down to 0.8
(this is referred in the text as Subset III, and denoted as density
range 0.8–1.0), allowing to cover a larger number of clusters and
source proteins. In this range of densities, we identified 441
clusters which contain 4489 peptides residing in 200 proteins
(Figure 1). It should be emphasized that such cluster densities (0.8–
1.0) still contain a rather large number of peptides per cluster (i.e.
20–22 peptides of 8–11 amino acids per fragment of 25 amino
acids). Out of the 441 clusters, we selected for experimental
evaluation 31 clusters encompassing an overall of 401 peptides
contained within 28 proteins (Figure 1). The 401 peptides were
analyzed for their ability to elicit a specific T-cell response (IFNc
production). This screen resulted in an overall of 43 responders
(distributed in 17 proteins), which constitute 10.7% of all peptides
tested in this subset (Figure 2 and Table S1). These findings further
corroborate the strength of the cluster-based approach as an
approach for selection and enrichment of true positives, and
validate the procedure, which was first exemplified for the highest
density clusters (1.0–1.4, Subset I, [14]), to the somewhat lower
densities (Subset III). The distribution of the epitopes according to
the extent of response (as measured by the number of spots
counted in a quantitative EliSpot assay, see Materials & Methods)
was generally found to be similar for the responders in Subset III
as for the responders in Subset I (Figure 3), where ,20% of the
responders induce production of IFNc at very high level (.=33
spots in the EliSpot assay).
We previously reported on a clear bias toward membranal
proteins detected for the 51 parental proteins of Subset I (cluster
densities 1.0–1.4) [14]. It was therefore interesting to determine if
such a bias exists for the 28 proteins antigens of Subset III, which
contain the clusters at lower densities of 0.8–1.0. Accordingly,
these 28 proteins were investigated for their structured topology by
prediction of transmembranal helices (see Materials and Methods
and Figure 4). The analysis reveals that about 72% of the above
mentioned 28 proteins are assigned as membranal proteins, similar
to the results obtained for the proteins in Subset I. This percentage
of membranal proteins is significantly higher (p,0.001) than that
observed for the whole genome (,30%) or for the group of
proteins in which the randomly selected predicted epitopes reside
(Subset II) (Figure 4).
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the high density clusters (1.0–1.4) that contain
responders (Subset IV)
The fact that the high density clusters that contain responders
reside in a relatively low number of proteins (41 ORF products), as
well as the structural bias of these 41 proteins (membrane-
spanning, see above) motivated us to determine whether the screen
based on epitope ‘‘hotspots’’ mapping resulted in convergence to
proteins which are immunogenic by nature. In such a case,
putative MHC peptides derived from these proteins could have
had a high probability of being immune responders, irrespective of
their location in or outside of a cluster of epitopes. The total
number of predicted MHC binders (with an IC50 value of 500 nM
and lower) contained in the 41 proteins is 3722 (Figure 1). Of these
3772 peptides, 3016 peptides are located outside the high density
(0.8–1.4) cluster regions (Figure 2). We randomly selected out of
these putative 3016 peptides 200 peptides for experimental
evaluation, and designated these as subset IV (Figures I and 2).
Out of the 200 peptides tested, only 4 peptides (2%) were found to
be responders (Figure 2 and Table S2). This percentage of
response is by far lower than the extent of response observed for
peptides in Subset I (10.2%) originating from high density cluster
regions within the evaluated 41 proteins. These results clearly
demonstrate that the major factor contributing to the enrichment
of responders is the clustering of epitopes rather than the nature of
the protein in which they are located. Nevertheless, one could
argue that the rather higher percentage of responder peptides
obtained in Subset IV (2%) in comparison to Subset II (0.4%)
might reflect a certain contribution of the protein nature to the
extent of response of its derived peptides (we note that the peptides
of subset II and subset IV were both selected at random from a
pool of putative MHC binders with predicted IC50 of 500 nM or
lower). Yet, the small number of responders in these two groups
(Subsets II and IV) does not allow for a statistically significant
Figure 1. Flowchart of down-selection of putative MHC binders for experimental evaluation. The whole-genome immunoinformatic
analysis conducted on the 1754 F. tularensis ORF products and the downstream selection of the various subsets of peptides is provided. Boxes shaded
in light blue: Subsets I and II were described in a previous study [14] and are added for the sake of completeness. Boxes shaded in cyan: Subsets III–V
of peptides selected and evaluated in this study. In all down selection steps referred to as : ‘‘Selected for evaluation’’ (in Subset III, IV and V), clusters
or peptides are selected at random as an operational filter for reduction of number of peptides to be experimentally tested, unlike Subset II, were
selection of peptides was at random with respect to clusters. Subset III contains 401 peptides selected from clusters having density of 0.8 up to 1.0
(1.0 not included); Subset IV is composed of 200 peptides selected from the overall 3016 predicted MHC binders (IC50,=500 nM) located outside the
high-density cluster regions in the 41 source proteins of Subset I (Figure 2); Subset V includes 92 predicted epitopes having an IC50 of 10 nM and
lower, representing putative high-affinity MHC binders.
doi:10.1371/journal.pone.0036440.g001
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subsets which include analysis of 700 putative MHC binders
permit to estimate with some confidence that the fraction of
responders among all predicted MHC binders in this bacterial
genome is within a range of 0.4–2%.
Conventional affinity-based screening strategy versus the
cluster-based approach (Subset V)
To further evaluate the performance of the cluster-based
approach as a filtering and enrichment strategy for identification
of CTL epitopes, we compared this approach to the classical
affinity-based approach. The classical approach relies solely on the
high predicted binding affinity of the peptides, based on the
documented correlation between MHC binding affinity and
immunogenicity [15,16,17,18]. Practically, a ‘‘strong’’ binder is
commonly defined as a peptide having an IC50 value of 50 nM
and lower. We chose to concentrate on a subset of peptides with a
predicted binding affinity of 10 nM at most. In accordance with
the experimental model (C57BL/6 mice), we focused on peptides
predicted to bind Kb and/or Db MHC alleles. Accordingly, a
total of 418 peptides predicted to have IC50 values of 10 nM or
less were identified in the whole genome of F. tularensis and from
these we chose at random 92 peptides for subsequent evaluation
(Subset V, Figure 1). As could be expected, the 92 peptides were
distributed in a relatively large number of proteins (87 proteins),
and of these 92 peptides, 9 peptides (9.8%) were found to be
responders (Figure 2 and Table S3). This percent of response is
similar to that obtained for peptides originating from density-rich
clusters (10.2–10.7%; subsets I and III). It was also interesting to
determine the distribution of the responder peptides of Subset V
with respect to the intensity of the response obtained, and to
compare it to the distribution in the cluster-based Subsets I and
III, (Figure 3). It appears that among the three Subsets I, III and
V, the pattern of distribution is by and large similar and the
proportion of peptides with high level of response is 10–20% and
about 50–70% have a rather low intensity of response. Yet, it
should be noted that the total number of responders in the high
affinity-based subset (Subset V) is smaller by an order of
magnitude than the number of responders in the cluster-based
subset (Subset III).
Figure 2. Array of peptides tested in the F. tularensis CTL screen in C57BL/6 LVS immunized mice. Summary of the total number of
peptides selected, evaluated and responding in the various subsets (see Figure 1). Data on Subset I and II is from [14]. Peptides which were shown to
stimulate lymphocytes and induce IFNc production are referred to as ‘‘responders’’. P-values are provided for evaluation of significance of difference
between number of responders in the cluster-based Subsets I and III versus Subset II, and versus Subset IV.
doi:10.1371/journal.pone.0036440.g002
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36440Figure 3. Magnitude of T-cell response among identified CTL epitopes (Subsets I, III, V). Responders identified from clusters with densities
of 1.0–1.4 (dark cyan) (determined from [14]), from clusters with densities of 0.8–1.0 (light cyan) and from the high affinity-based approach (light blue)
are classified according to magnitude of T-cell response, as deduced from number of spots in the EliSpot assay. The bars represent the percent of
responders per subset in each of the classes, while the actual number of responders is given in brackets on the top of the corresponding bar.
Classification (expressed in number of spots/million cells) is: Low: 5–20; Medium: 20–32; High.=33).
doi:10.1371/journal.pone.0036440.g003
Figure 4. Distribution of parental proteins containing responders according to their membrane topology. Parental proteins containing
responder peptides identified by the cluster-based, high affinity-based and random-based approaches are classified as follows: Membrane-spanning
proteins (with 10 or more predicted transmembranal domains (TM) and/or TMs spanning at least a third of the protein) in dark blue; partially
membranal proteins (less than 10 predicted TMs) in blue; proteins with no predicted transmembranal domains (except signal peptide) in light blue. .
P-values are provided for evaluation of significance of difference between membranal proteins in the cluster-based Subsets I and III versus Subset V
and versus Subset II.
doi:10.1371/journal.pone.0036440.g004
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model
The approach of cluster-based selection of putative MHC
binders was established and proven on C57BL/6 mice immunized
with the LVS F. tularensis strain ([14] and previous sections of this
manuscript). In order to examine the generality of this approach,
we repeated the evaluation of putative epitope located in highly
dense regions of predicted binders in a different allelic group
background. Out of the 545 clusters harboring a density of 0.8–
1.4, 484 clusters possess peptides with BALB/c restriction, of
which we selected 262 peptides for experimental evaluation on
splenocytes isolated from LVS immunized BALB/c mice (Table
S4). An additional pool of 108 peptides selected by the high
affinity-based approach described above and having a predicted
IC50 value lower than 10 nM, was tested in the BALB/c model
(Table S4). As shown in Table 1, the percent of responders
obtained is similar to values observed for the C57BL/6 model,
namely 11.1% vs. 10.4% for the cluster-based selected peptides
and 7.4% vs. 9.8% for the high affinity-based selected peptides.
Assessment of the T-cell population involved in the
peptide mediated cellular response
The cellular response elicited by the immunogenic peptides,
predicted to be MHC class I binders, was determined by following
the production of IFNc. Yet, an ultimate and decisive verification
of whether IFNc secretion is exclusively mediated by cytotoxic T-
cells and not by helper T-cells can be accomplished by addition of
antibodies inhibiting the IFNc secreted by either pathways. Such
verification may also be of value since for the cluster-based selected
peptides, a large fraction of the response is mediated by binders
with relatively low predicted affinity (median of IC50: 217 nM).
Accordingly, all 201 epitopes identified by the cluster-based
approach (Subsets I, III and the BALB/c screen), the 6 responder
peptides identified in Subsets II and IV as well as the 17 epitopes
identified by the high affinity-based approach (Subset V and the
BALB/c screen) were incubated with splenocytes (from C57BL/6
and BALB/c) supplemented with either anti-CD8 antibodies, anti-
CD4 antibodies or a mixture of both antibodies, and subjected to
the EliSpot assay (Figure 5). The complete information on the 222
responders of F.tularensis CTL, based on the analysis described
above, is compiled in Table S5.
Without exception, anti-CD8 antibodies completely inhibited
the IFNc-induced response mediated by the tested peptides, while
anti-CD4 antibodies did not alter the peptide-induced activity. We
note that the presence of both anti-CD4 and anti-CD8 was needed
to completely inhibit the killed LVS-mediated response. In
conclusion, we unequivocally confirmed that all the 222 F.
tularensis responder peptides, whether originating from the cluster-
based approach (Subsets I, III) or the high affinity-based approach
(Subset V), or the other subsets elicit a cytotoxic T-cell response
and not a helper T-cell response.
Discussion
Mapping the cellular immunome of a complex microbial
genome, i.e. a bacterial pathogen, by identification of CTL
epitopes, requires a rigorous filtering approach for down-selection
of peptide candidates for experimental evaluation, and preferably
an approach which enriches the extent of responders from the
tested pool. In this regard, the present study further validates and
expands the applicability of the cluster-based approach. The high
extent of response obtained in our previous study [14] for peptides
predicted to be MHC binders contained within regions rich in
putative MHC binders (density of 1.0–1.4) is now shown to be
attained also for peptide located in cluster regions of somewhat
lower densities (0.8–1.0). It should be noted that even a density of
0.8–1.0 still corresponds to a substantial number of peptides per
cluster region. Thus, a total of 43 novel CTL epitopes were
discovered, constituting 10.7% of the 401 peptides evaluated from
this subset of peptides (Subset III, Figure 2). The percent of
responders will obviously decrease at much lower densities and
indeed, predicted MHC binders chosen at random (Subset II)
which have an average cluster density of 0.2–0.3 exhibit a 17–25
fold lower percentage of responders as compared to that obtained
for cluster-based Subsets I and III (density 0.8–1.4). It should be
noted that the absolute value of the density per se is consequential
to the number of MHC alleles for which predictions are
performed. Therefore, in cases of high diversity in MHC alleles,
such as in humans, the criteria for cutoff of high density will
probably be much higher because clusters are expected to contain
much larger number of peptides per unit length.
Taken together, in the present and the previous studies 1641
peptides (Subsets I and III) located in high dense clusters were
evaluated in C57BL/6, resulting in identification of a total of 170
novel CTL responders. Among these 170 8-11mer responder
peptides, 44 peptides are ‘‘nested’’. This observation is the result of
the operational definition of a cluster, where putative epitopes
contained in a cluster are consecutive and may partially overlap.
In the case of ‘‘nested’’ peptides, it is apparently possible that the
longer peptide may be subjected to trimming processes, resulting
in the stimulation of the same T-cell population as that stimulated
by the embedded responder. Determining the actual MHC
binders among the nested peptides is beyond the scope of the
current study, but even if one considers only the 126 ‘‘unique’’
responders (to avoid redundancy in number of responders), the
percentage of responders is 7.7%, which is still significantly higher
(19-fold) than that observed for responders selected at random
(Subset II).
Investigation of the parental proteins of the responders with
respect to their membranal characteristic (Figure 4) reveals a clear
pattern of enrichment (70–80%) of membrane-integral proteins
among proteins harboring highly dense epitope regions (Subset I
as well as III) as compared to their prevalence in the whole
genome (30%) or to proteins containing responders identified and
selected at random (Subset II) or by high affinity (Subset V). The
broadly immunogenic nature of transmembrane regions was also
reported by others [19]. It is clear however that the factor of 2.5-
fold increase in enrichment of membranal proteins (in Subsets I
and III) would not account by itself for the high extent of response
in the cluster-based approach (which is at least 17-fold). In depth
inspection of cluster regions of Subset III within their parental
proteins reveal that out of the 31 clusters, 5 are embedded in non-
membranal protein (see a sample protein in Figure 6A), four of
Table 1. Comparison of cluster-based and high affinity-based
screens conducted in C57BL/6 and BALB/c mouse models.
Selection Approach Cluster-based High affinity-based
(density 0.8–1.4) (affinity,=10 nM)
Mouse model C57BL/6 BALB/c C57BL/6 BALB/c
# Peptides evaluated 1641 262 92 108
# Responders 170 29 9 8
% Responders 10.40% 11.10% 9.8% 7.40%
doi:10.1371/journal.pone.0036440.t001
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included in transmembranal proteins. About 70% of these clusters
are located in transmembrane helices while the remainders are
mostly located in inter-connecting loops (Figure 6B). A similar
observation was demonstrated previously for Subset I [14]. It is
worth noting that the distribution of non-clustered epitopes
between structural domains (e.g. peptides from Subset IV) is
comparable to the distribution of clustered epitopes. Therefore it
appears that the structural characteristics, i.e. transmembrane
domains, are not a discriminatory characteristic, further support-
ing our argument that localization in such hydrophobic domains
would not account by itself for the high extent of response in the
cluster-based approach.
To further demonstrate the generality of the cluster-based
approach, we extended the procedure which was carried out for
Subsets I–V on C57BL/6 mice with Kb/Db allelic restriction, to
BALB/c mice possessing Kd/Dd MHC alleles. Out of 262
peptides derived from highly dense clusters (densities of 0.8–1.4),
29 were found to elicit an immune response (11.1%), a success rate
which is similar to that obtained in the C57BL/6 model (Table 1).
One of the main goals of the present study was to compare the
cluster-based approach to the more conventional approach based
on predicted binding affinities of putative epitopes to MHC
molecules. In the latter, peptides are ranked according to their
predicted affinity, and the top-ranking peptides are selected as the
most likely immunogenic candidates. We have applied this
approach to the genome of F. tularensis and selected a group of
peptides predicted to be MHC binders with high affinity - IC50
values ,=10 nM. As expected, this approach yielded a high
percent of responders - 9.8% in C57BL/6 and 7.4% in BALB/c
(Table 1). The number of peptides selected from the cluster-based
approach with IC50 values lesser than 10 nM is 25. Of the 170
responders resulting from the cluster-based approach, only 5
peptides have an IC50 value lesser than 10 nM. The latter were
obviously included in the 418 peptides having an affinity of 10 nM
and less, but were not part of the 92 peptides selected for
evaluation, therefore no overlap could have been observed
between responders identified by the cluster-based approach and
responders identified by the high affinity-based approach. In this
context we should mention that neither the cluster-based nor the
high affinity-based screens were exhaustive (1641 out of 5729 and
92 out of 418 were tested, respectively, see Figure 2). In addition,
had we selected putative epitopes solely on the basis of their
predicted binding affinities (,10 nM), probably most of the 170
responders in C57BL/6 and the 29 in BALB/c would have been
missed. All peptides selected on the basis of the high cluster density
(0.8–1.4) and found to elicit an immune response have a range of
predicted IC50 values of 5–988 nM with a median value of
217 nM. Therefore, even if we would have selected peptides with
predicted affinities of ,100 nM, almost 70% of the responders
would have not been identified. However it is worth mentioning
that although these peptides may be considered to have medium
or relatively low predicted affinities it is possible that some of the
peptides can be trimmed further and thus the resulting shorter
peptides may have higher affinities, yet of the 130 peptides with
predicted affinities above 100 nM, about 55% are short peptides
(8 or 9mers). Note, that all of the responder peptides identified
were shown in the present study to elicit IFNc response which
could be inhibited by anti-CD8 but not CD4 antibodies (Figure 5).
Accordingly, the 201 cluster-based responder peptides and 17 high
affinity based responder peptides are true CTL F. tularensis
epitopes, validating again the reliability of the MHC prediction
tools for selecting such T-cell epitopes [20,21,22,23].
While no clear correlation exists between the intensity of the
response of a particular epitope and its predicted IC50 values, we
note that among the cluster-based peptides, there appears to be
some correlation between the level of response and the average
affinity (the geometric mean of predicted IC50 values being
183 nM for low-level responders and 160 nM and 117 nM for
medium and high-level responders, respectively). Moreover, there
appears to be an enrichment of peptides with higher predicted
affinities concomitant with increase in the density [14]. Overall,
the data demonstrate that the two approaches – high affinity based
and cluster based - are not mutually exclusive but are rather
Figure 5. Effect of anti-CD8 and anti-CD4 antibodies on the T-cell response. A sample of over 20 EliSpot plates is presented, in which each
of the first ten columns contains splenocytes incubated with an individual peptide and the last two columns are positive and negative controls,
containing splenocytes incubated with formalin killed LVS (LVS) and splenocytes devoid of antigen (No Ag), respectively. Rows 1 and 2 (duplicates)
contain splenocytes incubated with peptides denoted 001-010 (arbitrary numbering), or with LVS; the following pairs of rows (from top to bottom)
are repeats of rows 1 and 2 supplemented with anti-CD8, anti-CD4 or a mixture of anti-CD4 and anti-CD8 antibodies. All 222 F. tularensis responder
peptides exhibited the same behavior as depicted in the sample plate shown in this figure, with respect to the effect of anti-CD8 and anti-CD4
antibodies (see text and (Table S5)).
doi:10.1371/journal.pone.0036440.g005
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36440Figure 6. Distribution of clusters of CTL epitopes in a representative non-membranal and membrane-spanning protein and
alignment with transmembrane a-helices and loops. Sample plots of the topological map (generated by TMHMM predictions) of two
representative proteins. Red segments represent the probability of having a helical region, while the thin blue and pink lines represent inside and
outside loops, respectively. In the lower part of every protein chart, a bar represents a cluster of predicted epitopes. Co-localization of the putative
MHC binders with the predicted helix or loop region in the protein is marked by a grey box. (A) A sample of a non-membranal protein (gi|89256893)
carrying a cluster at density 0.8, harboring 23 putative epitopes, four of which are a responders. This represents the 18% non-membranal proteins
carrying high density clusters (see Figure 4). (B) A sample of a transmembrane protein (gi|89256946) carrying four clusters (clusters #1–4) within a a-
helical transmembrane domain, (marked by ‘‘TM’’), and an additional cluster (cluster #5) co-localized with an outside loop domain (marked by
‘‘loop’’) between two transmembranal regions. The total number of putative epitopes in clusters #1–4 is 102 and in cluster #5 is 17, which contain 3
and 2 responders, respectively. This sample protein provides an example for the high frequency of clusters in helical regions but also demonstrates
the presence of high density clusters in loops (there are examples of other proteins, not shown, where clusters span both transmembrane and loop
regions).
doi:10.1371/journal.pone.0036440.g006
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epitopes. The study reported here along with our previous study
[14] provides a total of 2803 evaluated putative MHC I binders of
which 222 are novel F. tularensis CTL epitopes, not documented
before (as deduced from inspection of the data deposited in the
comprehensive IEDB database, www.immuneepitope.org). This
large body of data increases very significantly the knowledge on F.
tularensis CTL epitopes.
Most if not all of the previous bacterial immunoinformatic
analyses were limited to subsets of preselected antigens mostly on
the basis of cellular location, or other functional characteristics or
some documented immunogenicity of the parental antigens
[12,13,24,25]. The challenge of an unbiased, whole genomic
immuno-analysis of a complex pathogen targeted for high-
throughput analysis, as mentioned above, is mainly to balance
between the very large number of predicted CTL epitope
candidates and an experimental cost-effective screen that would
yield a substantial fraction of the CTL-directed immune repertoire
of the organism. The percentage range of CTL epitopes expected
to reside in a bacterial proteome is still not well established and
would probably depends on the pathogenesis of the organism and
more specifically on the host-pathogen interactions, as well as on
whether the disease is chronic or acute. For F. tularensis which is an
intracellular obligatory pathogen causing an acute disease, we can
be guided by the data obtained in our experiments from the
percent responders of randomly selected predicted MHC binders
(Subset II (0.4% responders) and Subset IV (2% responders);
Figure 2). Accordingly, one can roughly estimate that out of all
90,879 peptides predicted as MHC binders in the F. tularensis
genome (Fig. 1), there should be ,1800 CTL epitopes or less. In
our cluster-based screen, we tested 1641 peptides, out of 5729
peptides (Subsets I and III) mapped from highly dense cluster
regions (densities 0.8–1.4) and identified 10.4% responders.
Therefore one can deduce that the total number of responders
out of the whole group of 5729 peptides would be ,600. This
number of epitopes is about a third of the above total estimated
number of CTL epitopes in F. tularensis. While this surprisingly
high percent of coverage of responders should be considered with
great caution, it appears that by rationally selecting only a small
fraction of the total predicted MHC binders one may recover a
substantial portion of all expected responders in the bacterial
genome. Considering the cluster-based approach success and
power in filtering and enrichment of true positive responders in F.
tularensis, we believe that this approach should be valuable and
applicable for whole-genome, unbiased identification of CTL
epitopes in other bacterial proteomes.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institute of Health. The
protocol was approved by the Israel Institute for Biological
Research Animal Care and Use Committee (Permit Number:
IACUC-IIBR M-32-2011).
Peptide synthesis
All peptides were synthesized by the 9-fluorenyl-methyloxycar-
bonyl (FMOC) chemistry and validated by mass spectrometry
(Sigma, Israel). Peptides were adjusted to 500 mM stock solutions
and stored at 220uC until use.
Preparation of splenocytes
Groups of C57BL/6 or BALB/c mice were immunized with
10
2 CFU LVS by the i.n route after anesthesia with Ketamine and
Xylazine. Six weeks later mice were euthanized, spleens removed
and splenocytes were prepared using a gentle MACS C-tube
(Milteny, Germany) according to the manufacturer’s instruction.
The freshly prepared splenocytes were suspended in RPMI-1640
supplemented with 10% heat inactivated fetal calf serum and
1 mM of Pen-Strep, non-essential amino acids, 2 mM L-
glutamine and sodium pyruvate. All tissue culture media and
related reagents were from Biological Industries, Bet Haemek,
Israel.
IFNc EliSpot assay
A single-cell suspension of fresh splenocytes (from either
C57BL/6 or BALB/c) was seeded in EliSpot 96-well plates
(MultiScreen Filter Plates, Millipore Ireland) at 10
6 cells per well in
complete RPMI medium containing 10 mM of each individual
peptide or 10
7 CFU/ml Formalin inactivated LVS as a positive
control in duplicates. The frequency of epitope-specific T
lymphocytes was determined after 24 hrs incubation at 37uC
using eBioscience IFNc EliSpot kits with strict adherence to
manufacturer’s instructions. A well was considered to be positive
when it contained .10 spots and had at least twice the number of
spots in negative control well. The background number of spots in
negative control wells never exceeded five spots per well. Virtually
all of the responses that were considered positive according to
these criteria were also positive by the two-tailed non-parametric
Mann–Whitney U-test (at p,0.05). Peptides which were shown to
stimulate lymphocytes and induce IFNc production are referred in
the text as responders.
For determination of CD4 or CD8 T cell response, responder
peptides at concentration of 10 mM were incubated with or
without 10 mg/ml anti-mouse CD4 (Functional Grade Purified,
clone GK1.5) or CD8 (Functional Grade Purified, clone 53-6.7)
monoclonal antibodies (eBioscience, San Diego, USA) and tested
for IFNc production by EliSpot assay as mentioned above.
Prediction of MHC class I putative binders
A total of 1754 F. tularensis ORF products (holarctica LVS
strain, GenBank accession AM233362) were subjected to analysis
for identification of putative CTL epitopes, by the MHC class I
predictor NetMHC3.0 using artificial neural networks (ANN) [26].
Mouse MHC alleles were considered (H2-Kb, H2-Db, H2-Kd,
H2-Dd). Predicted affinities (IC50, nM) for all 8, 9, 10, 11-mer
peptides were computed by the NetMHC3.0 predictor.
Cluster mapping and cluster density groups
A cluster of epitopes was defined as a polypeptide of up to 25
amino acids, containing at least 2 consecutive overlapping
predicted binders. The density of a given cluster was designated
as the number of predicted binders contained within the cluster
divided by its length. Maximal density of all mapped clusters in the
genome is 1.4. Clusters with a density equal or greater than 1 is
defined throughout the paper as cluster density group 1.0–1.4.
Clusters with densities 0.8 up to 1.0 (not including 1.0) is defined as
cluster density group 0.8–1.0.
Transmembranal helices and signal peptide predictions
Analysis of membrane protein topology was conducted by the
program TMHMM v2.0 [27] for prediction of transmembranal
helices based on hidden Markov model. Analysis of proteins for
presence of a signal peptide domain was performed by the Signalp
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transmembranal domains (TM) and/or TMs spanning at least a
third of the protein were assigned as membranal; Proteins
predicted to possess less than 10 predicted TMs were assigned as
partially membranal; proteins with no predicted transmembranal
domains except signal peptide were assigned as ‘‘No TMs’’.
Statistics
Statistical differences in EliSpot responses were determined
using the two-tailed non-parametric Mann–Whitney U-test.
Differences between number of responders obtained by the
different selection approaches and between number of transmem-
brane and non-transmembrane proteins in the various subsets
were determined using analysis of variance (ANOVA) and
Student-Newman-Keuls tests. P-values,=0.05 were considered
as significant.
Supporting Information
Table S1 List of 401 peptides selected from clusters of density
0.8 up to 1.0 (not including 1.0). The affinity provided is the IC50
value predicted for a particular responder sequence by the
NetMHC3.0 program. The gi number and annotation of the
source protein are according to the F. tularensis holarctica LVS
sequence deposited at the NCBI (GenBank accession AM233362);
(a) Responders are indicated by their magnitude of T-cell response
as follows number of spots/million cells) is: L (Low): 5–20; M
(medium) - 20–32; H (high) - 33 and above.
(PDF)
Table S2 List of 200 peptides contained in the 41 parental
proteins of responder peptides, and selected from regions outside
high density clusters (1.0–1.4) in these 41 proteins. The affinity
provided is the IC50 value predicted for a particular responder
sequence by the NetMHC3.0 program, and the threshold for
binding affinity is 500 nM. The gi number and annotation of the
source protein are according to the F. tularensis holarctica LVS
sequence deposited at the NCBI (GenBank accession AM233362);
(a) Responders are indicated by their magnitude of T-cell response
as follows number of spots/million cells) is: L (Low): 5–20; M
(medium) - 20–32; H (high) - 33 and above.
(PDF)
Table S3 List of 92 peptides selected from the high affinity-
based approach, having IC50 values,=10 nM. The affinity
provided is the IC50 value predicted for a particular responder
sequence by the NetMHC3.0 program. The gi number and
annotation of the source protein are according to the F. tularensis
holarctica LVS sequence deposited at the NCBI (GenBank
accession AM233362); (a) Responders are indicated by their
magnitude of T-cell response as follows number of spots/million
cells) is: L (Low): 5–20; M (medium) - 20–32; H (high) - 33 and
above.
(PDF)
Table S4 List of 370 peptides (262 selected by the cluster-based
approach - indicated as ‘‘clu’’ and 108 selected by the affinity-
based approach - indicated as ‘‘aff’’) tested in the BALB/c screen.
The affinity provided is the IC50 value predicted for a particular
responder sequence by the NetMHC3.0 program. The gi number
and annotation of the source protein are according to the F.
tularensis holarctica LVS sequence deposited at the NCBI
(GenBank accession AM233362); (a) Responders are indicated
by their magnitude of T-cell response as follows (number of spots/
million cells) : L (Low): 5–20; M (medium) - 20–32; H (high) - 33
and above.
(PDF)
Table S5 The list of peptides provides the compiled data of
responders from previously identified responders (Subsets I and II;
[14]) and every responder listed in Tables S1, S2, S3, S4.
(PDF)
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